Axsome Therapeutics (NASDAQ:AXSM) Research Coverage Started at Needham & Company LLC
Needham & Company LLC started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report released on Monday, MarketBeat.com reports. The firm issued a buy rating and a $130.00 price objective on the stock. Other analysts have also recently issued reports about the stock. Mizuho restated a buy rating and set […]
More Stories
Rockhopper Exploration (LON:RKH) Trading Up 13.2% – Should You Buy?
Rockhopper Exploration plc (LON:RKH – Get Free Report) shares rose 13.2% on Thursday . The stock traded as high as...
Crescent Energy (NYSE:CRGY) Sets New 52-Week High – Here’s What Happened
Crescent Energy (NYSE:CRGY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday ....
Odyssean Investment Trust (LON:OIT) Hits New 52-Week Low – Time to Sell?
Odyssean Investment Trust (LON:OIT – Get Free Report) hit a new 52-week low on Tuesday . The company traded as...
Rep. Lauren Boebert Pushes to Abolish the ATF
By Nathan Worcester Rep. Lauren Boebert (R-Colo.) has joined Rep. Eric Burlison (R-Mo.) in introducing legislation to abolish the Bureau...
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 8% – Here’s Why
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) fell 8% on Tuesday . The stock traded as low as $18.78...
Rugby Resources (CVE:RUG) Shares Down 25% – What’s Next?
Rugby Resources Ltd. (CVE:RUG – Get Free Report)’s stock price dropped 25% on Tuesday . The stock traded as low...